发明名称 Kappa opiatagonists for treating bladder diseases
摘要 <p>Use of asimadoline (N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2,-diphenyl- acetamide) (I) or its salts, for treating diseases of the bladder. ACTIVITY : Uropathic; Analgesic. Bladder irritation was induced in rats by intraperitoneal injection of 100 ml/kg of physiological saline ( J. Pharmacol. Exp. Ther., 79 (1943) 97). The animals were treated with (I), the bladders were emptied by abdominal massage, then urine was collected over the next 6 hours. (I) Doubled the amount of urine excreted. MECHANISM OF ACTION : Kappa opiate receptor agonist.</p>
申请公布号 EP1834640(A2) 申请公布日期 2007.09.19
申请号 EP20070111669 申请日期 2002.03.13
申请人 TIOGA PHARMACEUTICALS, INC. 发明人 JACOB, JUTTA;WEBER, FRANK;BARTOSZYK, GERD;SEYFRIED, CHRISTOPH
分类号 A61K31/40;C07D207/12;A61K31/401;A61P7/10;A61P7/12;A61P13/10;A61P25/02 主分类号 A61K31/40
代理机构 代理人
主权项
地址
您可能感兴趣的专利